Impfen Pro & Contra - Das Handbuch für die individuelle Impfentscheidung

population-based case-control study in North America. Pediatrics 1999, 103 (3): E28
    Li, S. T., Tancredi, D.J.: Empyema Hospitalizations Increased in US Children Despite Pneumococcal Conjugate Vaccine. Pediatrics 2010, 125: 25–33
    Lipsitch, M.: Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis 1999, 5 (3): 336–345
    Mathew, J. L.: Pneumococcal vaccination in developing countries: Where does science end and commerce begin? Vaccine 2009, 27 (32): 4247–4251
    Mbelle, N., Huebner, R. E., Wasas, A. D., Kimura, A., Chang, I., Klugman, K. P.: Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 1999, 180 (4): 1171–1176
    Metlay, J. P., Lautenbach, E., Li, Y., Shults, J., Edelstein, P. H.: Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era. Arch Intern Med 2010, 170 (8): 725–731
    Milde-Busch, A., Kalies, H., Rückinger, S., Siedler, A., Rosenbauer, J., von Kries, R.: Surveillance for Rare Infectious Diseases: is one passive data source enough for Haemophilus influenzae? Eur J Public Health 2008, 18 (4): 371–375. http://eurpub.oxfordjournals.org/content/18/4/371.full (Zugriff 14.12.2011)
    MMWR : Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease – United States, 1998–2003. MMWR Weekly, 16. September 2005, 54 (36): 893–897
    Muñoz-Almagro, C., Jordan, I., Gene, A., Latorre, C., et al.: Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008, 46 (2): 174–182
    Nasrin, D.: Antibiotic resistance in Streptococcus pneumoniae isolated from children. J Paediatr Child Health 1999, 35 (6): 558–561
    Nuorti, J. P., Butler, J. C., Farley, M. M., Harrison, L. H., et al.: Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000, 342 (10): 681–689
    O’Brien, K., Wolfson, L. J., Watt, J. P., Henkle, E., et al.: Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374: 893–902
    Örtkvist, A., Hedlund, J., Burman, L. A., et al.: Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group. Lancet 1998, 351 (9100): 399–403
    Peltola, H., Schmitt, J., Rooby, R.: Pneumococcal conjugate vaccine for acute otitis media – yes or no? Lancet 2003, 381: 2170f.
    Pelton, S. I., Huot, H., Finkelstein, J. A., Bishop, C. J., et al.: Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J 2007, 26 (6): 468–472
    Pelton, S. I., Klein, J. O.: The future of pneumococcal conjugate vaccines for prevention of pneumococcal diseases in infants and children. Pediatrics 2002, 110 (4): 805–814
    Quast, U., et al.: Impfreaktionen. Hippokrates Verlag (2. Aufl.), Stuttgart 1997
    Regev-Yochay, G., Dagan, R., Raz, M., Carmeli, Y., Shainberg, B.: Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children. JAMA 2004, 292 (6): 716–720
    Richmand, B. J.: Hypothesis: conjugate vaccines may predispose children to autism spectrum disorders. Med Hypotheses 2011, 77 (6): 940–947
    Rozenbaum, M. H., van Hoek, A. J., Hak, E., Postma, M. J.: Huge impact on assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevenar). Vaccine 2010, 28 (12): 2367–2369
    Rückinger, S., von Kries, R., Reinert, R., van der Linden, M., Siedler, A.: Childhood invasive pneumococcal disease in Germany between 1997 and 2003: Variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination. Vaccine 2008, 26 (32): 3984–3986
    Rückinger, S., van der Linden, M., Reinert, R. R., von Kries, R., et al.: Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine 2009, 27 (31): 4136–4141
    Singleton, R. J., Hennessy, T. W., Bulkow, L. R., Hammitt, L. L., et al.: